The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings

被引:67
作者
Williams, SM
Haines, JL
Moore, JH
机构
[1] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
关键词
D O I
10.1002/bies.10401
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The study of the genetics of complex human disease has met with limited success. Many findings with candidate genes fail to replicate despite seemingly overwhelming physiological data implicating the genes. In contrast, animal model studies of the same genes and disease models usually have more consistent results. We propose that one important reason for this is the ability to control genetic background in animal studies. The fact that controlling genetic background can produce more consistent results suggests that the failure to replicate human findings in the same diseases is due to variation in interacting genes. Hence, the contrasting nature of the findings from the different study designs indicates the importance of non-additive genetic effects on human disease. We discuss these issues and some methodological approaches that can detect multilocus effects, using hypertension as a model disease. This article contains supplementary material, which may be viewed at the BioEssays website at http://www.interscience.wiley.com/jpages/0265-9247/suppmat/index.html. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:170 / 179
页数:10
相关论文
共 101 条
[51]   Molecular mechanisms of human hypertension [J].
Lifton, RP ;
Gharavi, AG ;
Geller, DS .
CELL, 2001, 104 (04) :545-556
[52]   Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes [J].
Merrill, DC ;
Thompson, MW ;
Carney, CL ;
Granwehr, BP ;
Schlager, G ;
Robillard, JE ;
Sigmund, CD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :1047-1055
[53]   Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension [J].
Mondorf, UF ;
Russ, A ;
Wiesemann, A ;
Herrero, M ;
Oremek, G ;
Lenz, T .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (02) :174-183
[54]  
Moore Jason H, 2002, Pac Symp Biocomput, P53
[55]   The ubiquitous nature of epistasis in determining susceptibility to common human diseases [J].
Moore, JH .
HUMAN HEREDITY, 2003, 56 (1-3) :73-82
[56]   New strategies for identifying gene-gene interactions in hypertension [J].
Moore, JH ;
Williams, SM .
ANNALS OF MEDICINE, 2002, 34 (02) :88-95
[57]  
MOORE JH, 2002, LECT NOTES COMPUTER, P821
[58]   Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoter [J].
Morimoto, S ;
Cassell, MD ;
Beltz, TG ;
Johnson, AK ;
Davisson, RL ;
Sigmund, CD .
CIRCULATION RESEARCH, 2001, 89 (04) :365-372
[59]  
MPLETON AR, 2000, EPISTASIS EVOLUTIONA, P41
[60]   FULMINANT HYPERTENSION IN TRANSGENIC RATS HARBORING THE MOUSE REN-2 GENE [J].
MULLINS, JJ ;
PETERS, J ;
GANTEN, D .
NATURE, 1990, 344 (6266) :541-544